// September 21, 2023
Beyond TB medicines: How quality assurance is elevating health systems in Central Asia
In Central Asia and Eastern Europe, multidrug-resistant tuberculosis (MDR-TB) accounts for a sign
In Central Asia and Eastern Europe, multidrug-resistant tuberculosis (MDR-TB) accounts for a sign
The development of generic versions of innovator medicines is a global public health need.
Generic medicines have benefited millions of Americans and saved trillions of dollars.
The issue of addressing potential nitrosamine impurities in medicines has been the focus at event